SCHEMBL484816

SCHEMBL484816

CC(C)(C)OC(=O)N1CCC2(CCN(c3cccnc3)CC2)C1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.65
CYP11B2 P19099 1/20 0.62
GRM5 P41594 1/20 0.48
GRM1 Q13255 1/20 0.48
SCD5 Q86SK9 1/20 0.48
NAMPT P43490 2/20 0.46
HIF1A Q16665 1/20 0.46
ACACB O00763 3/20 0.46
CYP3A4 P08684 3/20 0.45
CYP2C19 P33261 2/20 0.45
MEN1 O00255 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP2C9 P11712 2/20 0.44
KIT P10721 1/20 0.44
CYP2D6 P10635 1/20 0.44
GBA1 P04062 1/20 0.44
USP30 Q70CQ3 1/20 0.44
CHRM4 P08173 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22941336 0.93 GPR119 (0.65) GPR119CYP11B2GRM5GRM1NAMPT
SCHEMBL2820398 0.93 GPR119 (0.71) GPR119CYP11B2GRM5GRM1NAMPT
SCHEMBL20798095 0.86 GPR119 (0.64) GPR119CYP11B2GRM5GRM1NAMPT
SCHEMBL484102 0.86 HIF1A (0.63) CYP11B2HIF1ACYP3A4CYP2C19MEN1
SCHEMBL594813 0.84 GPR119 (0.80) GPR119GRM5GRM1NAMPTCYP3A4
SCHEMBL484899 0.82 CYP11B2 (0.60) GPR119CYP11B2SCD5NAMPTHIF1A
SCHEMBL484770 0.82 CYP3A4 (0.54) HIF1ACYP3A4CYP2C19MEN1MAPK1
SCHEMBL13156810 0.81 CYP11B2 (0.61) GPR119CYP11B2SCD5NAMPTHIF1A
SCHEMBL25885002 0.81 CYP11B2 (0.56) GPR119CYP11B2SCD5ACACBMEN1
SCHEMBL30484800 0.81 CYP11B2 (0.56) GPR119CYP11B2SCD5ACACBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN GPR119 206/4885CYP11B2 2150/4885GRM5 1045/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN GPR119 206/4885CYP11B2 2150/4885GRM5 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.